Citation Impact

Citing Papers

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2012 Standout
The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells
2009
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
2019
C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion
2014 StandoutNobel
Ataxia telangiectasia mutated activation by transcription‐ and topoisomerase I‐induced DNA double‐strand breaks
2009 Nobel
Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study
2019
Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
2008
Cancer, Oxidative Stress, and Metastasis
2016
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Doxorubicin pathways
2010 Standout
Targeting tumor associated macrophages: The new challenge for nanomedicine
2017
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation
2009
Macrophages in immunoregulation and therapeutics
2023 Standout
Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
The role of iron and reactive oxygen species in cell death
2013 Standout
ATM Deficiency Results in Accumulation of DNA-Topoisomerase I Covalent Intermediates in Neural Cells
2013
Interactions between the Etoposide Derivative F14512 and Human Type II Topoisomerases: Implications for the C4 Spermine Moiety in Promoting Enzyme-Mediated DNA Cleavage
2011
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
Anthracycline associated cardiotoxicity in survivors of childhood cancer
2008
Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity
2011
Influence of processing on pharmacokinetic of typical constituents in radix polygoni multiflori after oral administration by LC–ESI–MS/MS
2013
Cardiovascular Complications of Cancer Therapy
2009
Oxidative Stress in Cancer
2020 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Proteomic analysis for anti-atherosclerotic effect of tetrahydroxystilbene glucoside in rats
2012
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
2016 StandoutNobel
Prevention of Anthracycline-Induced Cardiotoxicity
2014
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
2010 Standout
Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
2011
Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation
2010
Mechanism of Quinolone Action and Resistance
2014 Standout
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review
2014 Standout
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
2010
New Mechanistic and Functional Insights into DNA Topoisomerases
2013
Anthracycline Cardiotoxicity: From Bench to Bedside
2008
Childhood and adolescent cancer statistics, 2014
2014 Standout
Endosteal blade-vent implants.
1980
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
2008
Depletion of recombination-specific cofactors by the C-terminal mutant of the activation-induced cytidine deaminase causes the dominant negative effect on class switch recombination
2017 StandoutNobel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase
2015 StandoutNobel
The long-term efficacy of currently used dental implants: a review and proposed criteria of success.
1986 Standout
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Processing of Damaged DNA Ends for Double-Strand Break Repair in Mammalian Cells
2012
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
The Efficacy of Topoisomerase II-Targeted Anticancer Agents Reflects the Persistence of Drug-Induced Cleavage Complexes in Cells
2008
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Artificial Molecular Machines
2015 Standout
Drugging Topoisomerases: Lessons and Challenges
2012
Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
2016
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Beneficial Effects of THSG on Acetic Acid-Induced Experimental Colitis: Involvement of Upregulation of PPAR-γ and Inhibition of the Nf-Κb Inflammatory Pathway
2011
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
2013
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
2014
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines
2016
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Chemistry and Biology of DNA Containing 1,N2-Deoxyguanosine Adducts of the α,β-Unsaturated Aldehydes Acrolein, Crotonaldehyde, and 4-Hydroxynonenal
2009
APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination
2014 StandoutNobel
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
2018
(–)-Epigallocatechin Gallate, A Major Constituent of Green Tea, Poisons Human Type II Topoisomerases
2008
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
2016
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Dexrazoxane (Totect™): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy
2008
Functional requirements of AID’s higher order structures and their interaction with RNA-binding proteins
2016 StandoutNobel

Works of Yi Ban being referenced

Targeting Autocrine CCL5–CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity
2017
Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks
2009
Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients
2001
A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes
2008
Metastatic tumor cells – genotypes and phenotypes
2018
Effect of 2,3,5,4′-tetrahydroxystilbene-2-O-beta-d-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells
2007
Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane
2007
Rankless by CCL
2026